SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-22-004479
Filing Date
2022-01-14
Accepted
2022-01-14 17:13:40
Documents
158
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A calt-20201231x20fa.htm   iXBRL 20-F/A 364790
2 EXHIBIT 12.1 calt-20201231xex12d1.htm EX-12.1 10847
3 EXHIBIT 12.2 calt-20201231xex12d2.htm EX-12.2 10680
4 EXHIBIT 13.1 calt-20201231xex13d1.htm EX-13.1 7567
5 EXHIBIT 13.2 calt-20201231xex13d2.htm EX-13.2 6855
6 EXHIBIT 15.1 calt-20201231xex151.htm   iXBRL EX-15.1 2866257
7 EXHIBIT 15.3 calt-20201231xex15d3.htm EX-15.3 3766
  Complete submission text file 0001104659-22-004479.txt   17385159

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA calt-20201231.xsd EX-101.SCH 158672
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE calt-20201231_cal.xml EX-101.CAL 106431
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE calt-20201231_def.xml EX-101.DEF 464657
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE calt-20201231_lab.xml EX-101.LAB 991595
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calt-20201231_pre.xml EX-101.PRE 820169
152 EXTRACTED XBRL INSTANCE DOCUMENT calt-20201231x20fa_htm.xml XML 4375330
Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-39308 | Film No.: 22532651
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences